Fertility and Sterility
Volume 88, Issue 4 , Pages 781-784, October 2007

Substandard application of preimplantation genetic screening may interfere with its clinical success

  • Santiago Munné, Ph.D.

      Affiliations

    • Reprogenetics, Livingston, New Jersey
    • Corresponding Author InformationReprint requests: Santiago Munné, Ph.D., Reprogenetics, 3 Regent Street, Suite 301, Livingston, New Jersey 07039 (FAX: 973-992-1423).
    • ,
  • Luca Gianaroli, M.D.

      Affiliations

    • S.I.S.Me.R., Bologna, Italy
    • ,
  • Ilan Tur-Kaspa, M.D.

      Affiliations

    • Reproductive Genetics Institute, Chicago, Illinois
    • ,
  • Cristina Magli, Ph.D.

      Affiliations

    • S.I.S.Me.R., Bologna, Italy
    • ,
  • Mireia Sandalinas, M.Sc.

      Affiliations

    • Reprogenetics-Spain, Barcelona, Spain
    • ,
  • Jamie Grifo, M.D.

      Affiliations

    • New York University, New York, New York
    • ,
  • David Cram, Ph.D.

      Affiliations

    • Monash IVF, Clayton, Victoria, Australia
    • ,
  • Semra Kahraman, M.D.

      Affiliations

    • Istanbul Memorial Hospital, Istanbul, Turkey
    • ,
  • Yury Verlinsky, Ph.D.

      Affiliations

    • Reproductive Genetics Institute, Chicago, Illinois
    • ,
  • Joe L. Simpson, M.D.

      Affiliations

    • Florida International University College of Medicine, Miami, Florida

Received 29 July 2007; received in revised form 3 August 2007; accepted 3 August 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 S.M. is Director of Reprogenetics, a laboratory specializing in preimplantation genetic diagnosis. I.T.-K. has received research funding from Serono and is on the speaker's bureau for Organon. M.S. has a financial interest in Reprogenetics. Y.V. is owner and chief executive officer of Reproductive Genetics Institute, which operates clinics that provide preimplantation genetic diagnosis. J.L.S. is a member of the medical advisory board for Biocept and is a member of the scientific advisory board for IMETRIKUS.

PII: S0015-0282(07)03052-X

doi:10.1016/j.fertnstert.2007.08.002

Fertility and Sterility
Volume 88, Issue 4 , Pages 781-784, October 2007

Article Tools